Below are the most recent publications written about "Cell Cycle Proteins" by people in Profiles.
-
Wang YL, Zhao WW, Bai SM, Feng LL, Bie SY, Gong L, Wang F, Wei MB, Feng WX, Pang XL, Qin CL, Yin XK, Wang YN, Zhou W, Wahl DR, Liu Q, Chen M, Hung MC, Wan XB. MRNIP condensates promote DNA double-strand break sensing and end resection. Nat Commun. 2022 May 12; 13(1):2638.
-
Das D, Trivedi S, BlazĂcková J, Arur S, Silva N. Phosphorylation of HORMA-domain protein HTP-3 at Serine 285 is dispensable for crossover formation. G3 (Bethesda). 2022 May 06; 12(5).
-
Villodre ES, Hu X, Eckhardt BL, Larson R, Huo L, Yoon EC, Gong Y, Song J, Liu S, Ueno NT, Krishnamurthy S, Pusch S, Tripathy D, Woodward WA, Debeb BG. NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis. J Natl Cancer Inst. 2022 04 11; 114(4):579-591.
-
Park D, Gharghabi M, Reczek CR, Plow R, Yungvirt C, Aldaz CM, Huebner K. Wwox Binding to the Murine Brca1-BRCT Domain Regulates Timing of Brip1 and CtIP Phospho-Protein Interactions with This Domain at DNA Double-Strand Breaks, and Repair Pathway Choice. Int J Mol Sci. 2022 Mar 28; 23(7).
-
Maegawa S, Gopalakrishnan V. PLK inhibitors come of age in pediatric brain tumors. Neuro Oncol. 2022 03 12; 24(3):427-428.
-
Zhang N, Lin KF, Yang C, Peruski S, Pati D, Gilbertson SR. Synthesis and Evaluation of a Class of Compounds Inhibiting the Growth of Stromal Antigen 2 (STAG2)-Mutant Ewing Sarcoma Cells. ChemMedChem. 2022 05 04; 17(9):e202100653.
-
Piya S, Yang Y, Bhattacharya S, Sharma P, Ma H, Mu H, He H, Ruvolo V, Baran N, Davis RE, Jain AK, Konopleava M, Kantarjian H, Andreeff M, You MJ, Borthakur G. Targeting the NOTCH1-MYC-CD44 axis in leukemia-initiating cells in T-ALL. Leukemia. 2022 05; 36(5):1261-1273.
-
Das D, Seemann J, Greenstein D, Schedl T, Arur S. Reevaluation of the role of LIP-1 as an ERK/MPK-1 dual specificity phosphatase in the C. elegans germline. Proc Natl Acad Sci U S A. 2022 01 18; 119(3).
-
Deng Y, Yu L, Zhao Y, Peng J, Xu Y, Qin J, Xiao B, Liu S, Li M, Fang Y, Pan Z. RCC1 Expression as a Prognostic Marker in Colorectal Liver Oligometastases. Pathol Oncol Res. 2021; 27:1610077.
-
Guo E, Xiao R, Wu Y, Lu F, Liu C, Yang B, Li X, Fu Y, Wang Z, Li Y, Huang Y, Li F, Wu X, You L, Qin T, Lu Y, Huang X, Ma D, Mills GB, Sun C, Chen G. WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathway. J Exp Med. 2022 01 03; 219(1).